Macrophages Promote Axon Regeneration with Concurrent Neurotoxicity by Gensel, J.C. et al.
Cellular/Molecular
Macrophages Promote Axon Regeneration with Concurrent
Neurotoxicity
John C. Gensel,1 Satoshi Nakamura,2 Zhen Guan,1Nico van Rooijen,3Daniel P. Ankeny,1 and Phillip G. Popovich1
1Center for Brain and Spinal Cord Repair, Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University College of
Medicine, Columbus, Ohio 43210, 2Department of Neurosurgery, TokyoWomen’s Medical University Medical Center East, Tokyo 116-8567, Japan, and
3Department of Molecular Cell Biology, Vrije Universiteit, 1081 BT Amsterdam, The Netherlands
Activated macrophages can promote regeneration of CNS axons. However, macrophages also release factors that kill neurons. These
opposing functions are likely induced simultaneously but are rarely considered together in the same experimental preparation. A goal of
this study was to unequivocally document the concurrent neurotoxic and neuroregenerative potential of activated macrophages. To do
so, we quantified the length and magnitude of axon growth from enhanced green fluorescent protein-expressing dorsal root ganglion
(DRG) neurons transplanted into the spinal cord in relationship to discrete foci of activated macrophages. Macrophages were activated
via intraspinal injections of zymosan, a potent inflammatory stimulus known to increase axongrowth and causeneurotoxicity.Using this
approach, a significant increase in axon growthup tomacrophage fociwas evident.Within and adjacent tomacrophages, DRGand spinal
cord axons were destroyed. Macrophage toxicity became more evident when zymosan was injected closer to DRG soma. Under these
conditions, DRG neurons were killed or their ability to extend axons was dramatically impaired. The concurrent induction of pro-
regenerative and neurotoxic functions in zymosan-activated macrophages (ZAMs) was confirmed in vitro using DRG and cortical neu-
rons. Importantly, the ability of ZAMs to stimulate axon growth was transient; prolonged exposure to factors produced by ZAMs
enhanced cell death and impaired axon growth in surviving neurons. Lipopolysaccharide, another potentmacrophage activator, elicited
a florid macrophage response, but without enhancing axon growth or notable toxicity. Together, these data show that a single mode of
activation endows macrophages with the ability to simultaneously promote axon regeneration and cell killing.
Introduction
There is compelling evidence that macrophages derived from
microglia and blood monocytes can promote regeneration of
CNS axons. However, macrophages also can kill neurons and glia
(for review see, Stoll et al., 2002). At first glance, these divergent
effects seem mutually exclusive. This perspective is often rein-
forcedwhen an experimental design seeks to document indices of
repair or injury. Rarely are experiments designed to simulta-
neously document the pro-regenerative and neurotoxic effects of
macrophages.
Data from variousmodels suggest that macrophages can elicit
injury and repair simultaneously or as part of an activation con-
tinuum. For example, in a model of myocardial infarction, inju-
rious functions are attributed to monocytes recruited early,
whereas later infiltratingmonocytes promote repair (Nahrendorf
et al., 2007). In a gliomamodel,macrophages possessing injury or
repair characteristics are simultaneously recruited to the tumor
(Umemura et al., 2008). In theCNS, different experimental prep-
arations have reinforced the notion that macrophages exert po-
larized effects. For example, intraparenchymal injections of zy-
mosan (a yeast cell wall component and potent macrophage
stimulus) were used originally to model the injurious effects of
macrophages activated by CNS trauma without consideration of
their pro-regenerative potential (Fitch et al., 1999; Popovich et
al., 2002). Conversely, the Benowitz laboratory showed that
zymosan-activated macrophages (ZAMs) promote regeneration
of retinal ganglion cell (RGC) axons (Yin et al., 2003). Similarly,
ZAMs were shown to promote functionally significant regenera-
tion of injured dorsal root ganglion (DRG) axons (Steinmetz et
al., 2005). An important but often overlooked observation in the
original report by Yin et al. was that ZAMs also killed a large
number of RGCs in vitro. This important observation has been
overshadowed by the repair capacity of ZAMs. Indeed, follow-up
studies concentrated on identifying only the pro-regenerative
molecule(s) released by ZAMs (Yin et al., 2006).
To better understand if a single stimulus can cause macro-
phages to promote neurotoxicity and regeneration in the CNS,
we combined a well established nontraumatic DRG transplanta-
tion technique with intraspinal zymosanmicroinjections (Davies
et al., 1997, 1999; Popovich et al., 2002). Because zymosan elicits
a pluripotent macrophage response, it is ideal for exploiting the
dual nature of macrophage activation. Here, we show that ZAMs
modify the surrounding microenvironment and significantly in-
crease axon growth; however, this is accompanied by axon loss
and cell deathwithin andnearby activatedmacrophages. Toxicity
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was enhanced, and regeneration was decreased when macro-
phages were activated closer to the soma of DRG neurons. In
vitro, ZAM-derived factors transiently promote DRG axon
growth. Ultimately, ZAMs killed most neurons in vitro and in
vivo. For those neurons that survived, axon growth/sproutingwas
reduced. The pro-regenerative and neurotoxic effects of macro-
phages were stimulus specific. Indeed, lipopolysaccharide (LPS)-
activated macrophages failed to enhance axon growth and were
only mildly neurotoxic. Together, these data show that a single
mode of activation endows macrophages with the ability to si-
multaneously promote axon regeneration and cell killing. Addi-
tional work is needed to determine whether these macrophage
functions can bemodified to selectively enhance only those func-
tions that promote repair.
Materials andMethods
Dissociation and preparation of DRG cells. Single-cell suspensions of cer-
vical, thoracic, and lumbar DRG neurons were prepared from the spinal
cord of anesthetized adult (2–3 months of age) transgenic enhanced
green fluorescent protein (EGFP) mice (C57BL/6-Tg(ACTB-
EGFP)1Osb/J; The Jackson Laboratory) (Lindsay et al., 1991). Dissected
DRGs were incubated in dispase 2 (5 U/ml; Roche) and collagenase type
2 (200 U/ml; Worthington) for 45 min at room temperature in calcium
and magnesium-free HBSS (Mediatech) (Davies et al., 1999). Enzymes
were removed, and 250 g/ml DNase1 type 2 (Sigma) was added to the
medium for 5 min. DRGs were triturated in 500 l of HBSS medium
through Pasteur pipettes and spun at 3000 rpm for 180 s. The neuron-
enriched pellet was resuspended in 20–70 l of L15 medium (Invitro-
gen) with 5 g/ml DNase1 type 2 for an average neuronal density of 680
cells per microliter.
Figure1. An in vivomodel for assessinggrowth/regenerationof adefinedaxonpopulation.AdultmouseEGFPDRGneuronswere transplanted into theadult rat cervical (C1/2) spinal cordusing
the technique described by Davies et al. (1999). Eight days after transplantation, DRG axons extend into the spinal cord rostral and caudal from the injection site. A, A confocal montage of a sagittal
section of the spinal cord 8 d after transplantation.B–D, High-powermontage of boxed areas in A showing the relationship between GFP axons (green) and GFAP astrocytes (red) throughout
the rostral (B) and caudal (D) axes of the intact spinal cord. Scale bars: A, 875m; B–D, 200m.
Figure 2. ZAMs promote axon growth in the spinal cord. A,B, Confocal montages of GFP DRG axons growing toward a site of zymosan (A) or control (B) injection4mm caudal to the site of
DRG transplantation. These images are representative of the average caudal axon growth from each group. Note the significant increase in axon growth toward foci of ZAMs (dotted circle) in A. C,
Quantification of axonal outgrowth from the graft reveals a significant increase in axon growth in spinal cords injected with zymosan. *p 0.05 versus controls over the distance measured.
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DRG transplantation and intraspinal macrophage activation. Adult fe-
male Sprague Dawley rats (200–225 g; Harlan) were anesthetized with
subcutaneous ketamine (80mg/kg) and xylazine (50mg/kg). A laminec-
tomy was performed to expose either the cervical or thoracic spinal cord.
The C1/2 junction of the cervical spinal cord was exposed, and the dura
and piamatter was removed. Animals were secured with spinous process
clamps on residual C1 and C3 vertebrae, and microinjections were per-
formed via calibrated pressure microinjection (PV800 Pneumatic Pi-
coPump; David Kopf Instruments) using pulled glass micropipettes
(PD-5Micropipette Puller; Narishige). Pipettes were beveled to an exter-
nal diameter of 30–80 m (Beveller 1300M-C; World Precision Instru-
ments) andwere sterilized overnight under UV light. To target the dorsal
columnwhite matter, stereotaxic injections were made 400m lateral to
midline and 600mdeep (Popovich et al., 2002). DRG suspensions (750
nl) were microinjected into the C1/2 junction using a 55- to 80-m-
diameter beveled tip glass pipette and were monitored through a micro-
scope to confirm consistent transplant delivery. For data in supplemental
Figure 1 (available at www.jneurosci.org as supplementalmaterial), DRG
neurons were injected into the C3 cervical spinal cord.
To align transplanted DRGs with regions of macrophage activation
caudal to the transplant site, macrophage activating factors were micro-
injected at the time of DRG transplantation. All injections were posi-
tioned 400m lateral to midline and 600mdeep into the parenchyma.
Shamcontrol injections (pipette insertionwithout injection), or 100 nl of
vehicle (saline), zymosan (10 mg/ml; Sigma), or LPS (2 mg/ml, from
Escherichia coli 055:B5; Sigma), were delivered 2 or 4 mm caudal to the
injection site using a glass pipette of 30m(sham, vehicle, LPS) or 50m
(zymosan). A small subset of animals received vehicle or zymosan injec-
tions 4mm rostral toDRG injections into the C3 cervical spinal cord. For
three-dimensional reconstructions and analysis of macrophage deple-
tion, 50 nl injections of zymosan (12.5 mg/ml) were delivered 1–1.2 mm
lateral to midline and 500–700 m deep into the thoracic spinal cord at
the T8/T9 vertebral level (Popovich et al., 2002). Intraganglionic injec-
tions of zymosan (100 nl) or PBS (50 nl) were made into the L4 or L5
lumbar DRG. The three-dimensional reconstruction of a zymosan injec-
tion site (see Fig. 3) was created using the M3D plug-in for the MCID
system (InterFocus Imaging). The area containing round, activated
OX42 cells was manually outlined on 29 sections spanning3 mm of
spinal cord. The density of OX42 immunoreactivity emanating from the
center of maximal OX42 labeling was then labeled by densitometric
thresholding over the same distance.
Macrophage depletion and analysis of zymosan injection sites. Clodr-
onate (a gift from Roche Diagnostics) was encapsulated in multilamellar
liposomes and injected as described previously (van Rooijen and Sand-
ers, 1994; Popovich et al., 1999). Briefly, liposomes or PBS were injected
into the tail vein (2 ml per injection in PBS) 1, 3, and 6 d after intraspinal
injection of zymosan. Injections were performed under brief inhalation
anesthesia with isoflourane. PBS is the proper control for clodronate
Figure 3. Zymosan-activated macrophages modify the surrounding microenvironment creating passages for axon growth. A, B, A three-dimensional (3D) schematic showing the formation of
a graded column of activated microglia and macrophages emanating from a zymosan injection site (A, B, D, green). Phagocytic monocyte-derived macrophages (MDMs) occupy the center of the
injection site (see also Fig. 8) (Popovich et al., 2002). Activatedmicroglia (blue) lie adjacent toMDMsand forma columnof activated cells that extends for severalmillimeters.C,D, A two-dimensional
representation of spinal cord sections stained for microglia/macrophages (OX42 antibody), then rendered in third dimension in A and B. Green shading corresponds with the center of the injection
site and the areawhereMDMs infiltrate. These areas weremanually outlined for 3D rendering. Blue shading correspondswith automated threshold scans of OX42microglia inwhitematter. GM,
Graymatter.E,F, Graded levels ofmyelin loss (MBP; red) surround the zymosan injection site. EGFPDRGaxons (green) grow through regions of intact anddegeneratingmyelin into areas occupied
by activated microglia. Axon growth is diminished or aborted immediately adjacent to sites of MDM accumulation (dotted line in F ). Scale bar: A, B, 34m; C, D, 186m; E, F, 200m.
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liposomes because liposome-encapsulated PBS alters the function of
healthy macrophages (Popovich et al., 1999; Gray et al., 2007). In Figure
9, zymosan injection sites were identified for each animal by identifying
the tissue section containing the largest region of round OX42macro-
phages. Lesion size was determined by manually outlining areas devoid
ofmyelin or axon labeling. Themagnitude ofmacrophage activationwas
quantified and expressed as the total area of OX42 immunoreactivity.
Tissue processing and immunohistochemistry. At various times after
injection, rats were anesthetized and perfused transcardially with 200
ml of cold 0.1 MPBS and 300ml of 4%paraformaldehyde. Spinal cords or
DRGs were removed, rinsed in 0.2 M phosphate buffer (PB), and stored
overnight. Tissues were cryoprotected by immersing them in increasing
concentrations of sucrose (10–30%) over several days, blocked, embed-
ded in OCT compound, and frozen on dry ice. Frozen spinal cord blocks
were sectioned on a cryostat at 30 m in the parasagittal plane (aligned
parallel to the central canal) or at 10m in the transverse plane (frontal).
Sequential sections were collected on Superfrost Plus slides (Thermo
Fisher Scientific). For immunohistochemical labeling, sections were
washed in 0.5 M Tris buffer (TB), permeablized with 1.0% Triton X-100/
0.2 M PB, and incubated overnight with primary antibodies prepared in
blocking solution. Secondary and tertiary steps for single, double, and
triple staining were performed using standard immunocytochemical
methods. Antibodies against GFP (1:800; rabbit; Invitrogen) were used
to label transplanted DRG neurons. Primary monoclonal antibodies
were used to label astrocytes [glial fibrillary acidic protein (GFAP);
1:1000; rabbit; Dako Denmark], microglia/macrophages (OX42; 1:500;
mouse, AbD; Serotec), ciliary neurotrophic factor (CNTF; 1:800; goat; R
& D Systems), or myelin basic protein (SMI-94; 1:20,000; Sternberger
Monoclonals). Biotin-conjugated lectin fromWisteria floribunda agglu-
tinin (WFA; 15 g/ml; Sigma) was used to label chodroitin sulfate pro-
teogylcans (CSPG) (Bruckner et al., 1998). Alexa Fluor 488 (AF488)-,
AF546-, or AF633 (1:1000)-conjugated secondary antibodies were used
to visualize primary antibody labeling. DRAQ5 (1:3000; Biostatus Lim-
ited) orDAPI (4,6-diamidino-2-phenylindole;
Sigma) was added to secondary antibodies to
label cell nuclei. Fluoromyelin (Invitrogen) was
used according to the manufacturer’s specifica-
tions to label myelin. A subset of sections was
stained for macrophages/microglia (OX42;
1:4000;mouse, AbD; Serotec), GFP (1:800; rab-
bit; Invitrogen), or axons (NF200; 1:5000; rab-
bit; Millipore Bioscience Research Reagents)
using peroxidase-based immunohistochemis-
try or eriochrome cyanine and cresyl violet, for
myelin and cell nuclei, respectively.
Analysis of axon length. For analysis of DRG
axon growth, serial sections were analyzed
through the width of the DRG transplant site.
Cases in which activated macrophage foci were
500 m from their intended location (2 or 4
mm caudal to the DRG transplant) and/or
transplants did not extend axons into the spinal
cord parenchyma (2 mm of zymosan; see Re-
sults) were excluded. Because no significant dif-
ferences in DRG axon growth were detected be-
tween groups receiving sham or vehicle control
injections, whether injected 2 or 4mmcaudal to
the DRG transplant, the groups were collapsed
for analyses. Final numbers for each groupwere
as follows: control (for zymosan), n 9; 4 mm
of zymosan, n  5; 2 mm of zymosan, n  12;
control (for LPS), n 8; 4 mm of LPS, n 5; 2
mm of LPS, n  3. The maximum distances
reached by DRG axons from the center of the
DRG transplant (rostral and caudal) were
quantified using an Axioplan 2 imaging micro-
scope (Zeiss) with a motorized X–Y stage con-
trolled byMCID image quantification software.
The density of DRG axon growth was deter-
mined for each animal in sections containing
the largest DRG transplant (as determined by GFP labeling). Total
axon density was estimated in regular intervals from the edge of the
transplantation site to the point of the longest axon by quantifying the
area of GFP labeling above threshold in a standardized sample box (1
mm2).
The MCID software was used to detect and enumerate cresyl violet-
stained DRG neuronal profiles at sites of intraganglionic zymosan injec-
tions (see Fig. 8). A MetaMorph image analysis system (Molecular De-
vices) was used to analyze the gradient intensity of CNTF labeling across
an arbitrary sample line extending from the site of DRG transplantation
to the area of macrophage activation (see Fig. 4).
Macrophage-conditioned medium. Bone marrow-derived macro-
phages were obtained from adult C57BL/6 mice as described previously
(Longbrake et al., 2007). After 6 d in culture,macrophages were removed
from flasks using a cell scraper and resuspended in Neurobasal A (NBA)
medium supplemented with 2% B27, 1% Glutamax, and 1% penicillin–
streptomycin. Cells were replated in six-well plates at 10 106 cells/well.
The following day, mediumwas replaced with NBA containing zymosan
(1.25 mg/ml), LPS (100 ng/ml), or fresh NBA. Macrophages were acti-
vated for 8 h at 37°C in 5% CO2, after which the macrophage-
conditioned medium (MCM) was collected, centrifuged (1200 rpm, 5
min), and filtered (0.22 m low-protein binding filter; Millipore) to
remove the zymosan particles, LPS, and cell debris. All MCMs were
stored at20°C.
In vitro analysis of DRG neurons. Suspensions of DRG neurons were
prepared as described above. Neurons were suspended in NBA medium
with supplements (see above) and plated onto coverslips at 500 cells/
coverslip. All coverslips were precoated with 0.1 mg/ml poly-L-lysine
(Sigma) and 10 g/ml laminin (Roche). All medium components were
obtained from Invitrogen. Three to four days after platingDRGneurons,
50% of the medium was removed and replaced with MCM as described
above.DRGneuronswere incubatedwithMCMfor 24 or 48 h.Cells were
Figure 4. ZAMs induce a gradient of CNTF expression. A–C, Parasaggital section of spinal cord transplantedwith DRG neurons
and injected with zymosan4 mm caudal to the transplant. Individual confocal scans show EGFP axons (A, green) and CNTF
immunoreactivity (B, red). Merged images show nuclear labeling (DRAQ5; C, blue). Note that DRG axons grow toward ZAMs
through a dense CNTF astroglial substrate then stop abruptly at ZAM interface. A linear scan of staining intensity between the
DRG transplant site and the core of ZAMs shows an increase in CNTF immunoreactivity closer to the zymosan injection site; CNTF
labeling is noticeably absent from the ZAMcore.D–F, High-powered confocal images show that GFAP astrocytes (D, green) are
the predominant source of CNTF (E, red). Merged images show nuclear labeling (DRAQ5; F, blue). Scale bar: A–C, 200m; D–F,
7.5m.
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then washed with 0.1 M PBS and fixed with 2%
paraformaldehyde for 30 min. A monoclonal
anti--tubulin III antibody was used to label
DRG neurons (1:2000; Sigma). AF546-
conjugated secondary antibodies (1:1000) were
used to detect labeledDRGneurons. Four to six
coverslips were generated for each experimen-
tal condition. At least three independent exper-
iments were conducted for each in vitro
manipulation.
MCM effects on DRG survival were deter-
mined by performing unbiased counts of the
number of -tubulin III cells that remained
on each coverslip after 24 or 48 h of stimulation.
Briefly, 45% of each coverslip was randomly
sampled (125 fields per coverslip) using the
stereology feature of the MCID image analysis
software. A cell was counted as an intact DRG
neuron if it had neuronal morphology, ex-
tended at least one process, and had no dystro-
phic axons. To quantify axon growth, 10 cells
per coverslip (40 total cells per condition) were
randomly selected for analysis. Only cells with
isolated processes that did not contact other
cells or cell processes were quantified. To re-
duce human bias, an automated Sholl (1953)
analysis program was developed using the
MetaMorph image analysis system. Templates
of concentric circles of 50 m intervals were
overlaid onto the center of a digitized DRG
soma. For each neuron, densitometric thresh-
olds were set to remove background labeling
and identify detailed cellular processes. Single
pixels of immunoreactive labeling above the
threshold of detection were removed to reduce
false positives. The total number of objects
above threshold intersecting each circle was tal-
lied using an automated macro. The maximal
ring with an intersecting process (maximum
distance) and sum of the number of intersec-
tions (branching complexity) for all rings were
generated for each cell and compared among
groups.
Cortical neuron toxicity assays. Cortical neu-
ron suspensions were prepared from 2–3 d
postnatal mouse pups. After decapitation, the
cortex was dissected, minced, and placed in 1.5
mg of papain prepared in 4 ml of L15/BSA. So-
lutions were rotated at 100 rpm for 15 min at
37°C. After settling, tissues were repeatedly
washed in NBA and triturated using pipettes of
increasingly smaller diameter. Cells were cen-
trifuged in NBA/B27 medium containing 25%
serum for 6 min at 1200 rpm. Supernatants
were discarded, and cells were resuspended in
fresh NBA/B27. Cortical neurons were plated in 96-well plates at a den-
sity of 30,000 cells/well. The medium was changed every 3–4 d. Seven to
ten days after plating, 50% of the medium was exchanged with fresh
medium: MCM prepared as described above or 100 M glutamate (pre-
pared in NBA/B27). Cortical neurons were stimulated for 24 h, washed
with 0.1 M PB, and fixed with 2% paraformaldehyde for 30min. For each
experiment, six replicate wells per condition were prepared.
Cortical neuron survival was assessed using an ELISA-based assay as
described previously (Mallat and Chamak, 1994; Brooke et al., 1999).
After fixing, cells were washed twice with 0.1 M PBS and then twice with
0.1 M PBS/0.1% Triton X-100. Washed cells were then incubated for 1 h
at 60 rpm in 10% FBS/0.1 M PBS/0.1% Triton X-100. After this blocking
step, anti-MAP2 antibodies (mouse anti-SMI-52; 1:1000 prepared in
blocking solution; Covance) were added to each well overnight at 4°C.
The next day, cells were washed three times and incubated with biotin-
ylated goat anti-mouse IgG1-alkaline phosphatase (1:1000 in blocking
solution; Southern Biotechnology) for 2 h at room temperature. Cells
were washed a final time, this time substituting 0.5 M TB for PBS, and
incubated in pNPP phosphatase substrate. The 96-well plate was inserted
into a SpectraMax 190 micro plate reader (Molecular Devices). The re-
action was monitored for 30–240 min at 405 nm as the remaining alka-
line phosphatase hydrolyzed the pNPP introduced. The amount of pNPP
hydrolysis was proportional to the amount of bound alkaline phospha-
tase. This reflects the number of neurons present in eachwell. The optical
density was detected for each well and compared between groups.
Statistical analysis. To maximize statistical power and reduce family-
wise error, systematic comparisons were made using independent t tests
between control conditions. If no significant differences were detected,
Figure 5. Abortive axon growth occurs at the border of ZAMs. A, B, EGFP axons (green) stop growing or turn as they
approach or enter ZAM foci (OX42; red). Note the phagocytic inclusions of GFP remnants (appear yellow) in ZAM (see also Fig. 6).
B is a higher-power image of the box in A. C–E, Abortive axon growth at the ZAM interface colocalizes with dense accumulation
of CSPGs (WFA; D, E, red). All nuclei are stained with DRAQ5 (blue). Scale bar: A, 875m; B, 350m; C–E, 100m.
Figure 6. Fragments of growing or degenerating DRG axons are engulfed as they enter areas containing ZAMs. A, EGFP
axons grow toward ZAM foci, then turn (see also Fig. 5) or become fragmented (die back). EGFP inclusions are evident within
macrophages (arrow).B–D, High-power Z-stack of EGFPDRGaxon fragments (green) engulfed byOX42macrophages (red).
Scale bar: A, 125m; B–D, 12m.
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conditions were collapsed to increase statistical power. Grubb’s test
(extreme Studentized deviate method; http://www.graphpad.com/
quickcalcs/Grubbs1.cfm) was used to remove statistical outliers. Data
were analyzed using ANOVA followed by Dunnett’s or Tukey’s test for
multiple comparisons. Independent-samples t tests were also used to
compare two groups separately. Pearson’s correlation coefficient was
used to determine the statistical significance of regression data. All p
values 0.05 were considered significant. Unless noted otherwise, all
data represent the mean 	 SEM. All analyses were performed using
Prism 5.0 (GraphPad Software). Figures were prepared using Adobe
Photoshop CS (Adobe Systems) and Prism 5.0.
Results
ZAMs create a growth permissive environment and support
axon regeneration in vivo
To evaluate the ability of activatedmacrophages to promote axon
regeneration in the spinal cord, we modified the protocol de-
scribed by Davies et al. (1997, 1999). After micro-transplanting
adult DRG neurons into the dorsal columns of the intact cervical
spinal cord, growing axons were easily distinguished from host
axons (Fig. 1). DRG axons grew rostral and caudal to the trans-
plant site at rate of0.7 mm/d (Fig. 1).
Using this model, we asked whether focal intraspinal macro-
phage activation could enhance the growth of transplanted DRG
axons in the spinal cord. Supplementing the injured spinal cord
with activated macrophages caudal to the site of injury has been
shown to promote axon regeneration in animals and was used in
clinical trials to treat acute spinal cord injury (SCI) (Rapalino et
al., 1998; Knoller et al., 2005). In an effort to maximally lure the
growth cones of DRG axons into a microenvironment condi-
tioned by activated macrophages, zymosan was injected 4 mm
caudal to the site of DRG transplantation. DRGs and zymosan
were injected at the same time to ensure that growing axons
would approach the macrophage foci at the time of maximal
macrophage activation (3 d after injection) (Popovich et al.,
2002; Schonberg et al., 2007).
When compared with vehicle injection (saline) or micropi-
pette alone, ZAMs increased the density of axons exiting the graft
and the maximal distance that they grew (Fig. 2) [average length
of longest axon (in mm), 3.2	 0.5 (control) vs 4.8	 0.4 (zymo-
san); p 0.05]. This may be a result of ZAMs creating a growth-
permissive environment surrounding the inflammatory focus.
Indeed, a “tunnel” of reactive microglia projected from the ZAM
foci and colocalized with regions of demyelination (Fig. 3). A
gradient of activated astrocytes also radiated from the ZAM foci
as evidenced by increasing CNTF expression (Fig. 4).
DRG axons grew in straight trajectories through these tunnels
and became tortuous or dystrophic as they reached the ZAM foci,
often turning away from these cells (Figs. 3, 5). The abortive axon
growth in and around areas containing ZAMs was associated
with enhanced CSPG expression (Fig. 5) and enhanced phago-
cytic uptake of degenerating axon terminals (Fig. 6; supplemental
Fig. 1, available at www.jneurosci.org as supplemental material).
Phagocytic GFP inclusions were observed in ZAMs in all
(100%) samples in which axons could be found approaching the
interface. Importantly, no GFP inclusions were found in acti-
vatedmicroglia/macrophages surrounding the site of DRG injec-
tion (data not shown).
Zymosan injections created a dense, focal site of macrophage
activation that was contained in the ascending dorsal columns.
Because ZAMs can cause axotomy (Popovich et al., 2002), a field
ofWallerian degeneration could be created in the dorsal columns
between the zymosan andDRG injection sites. Consequently, the
onset of CNTF upregulation or other pro-regenerative cues em-
anating from intratract glia could enhance regeneration. How-
ever, by reversing the position of the DRG transplant and the
zymosan injection so that transplanted DRG neurons were posi-
tioned caudal rather than rostral to the zymosan injection site,
Wallerian degeneration would proceed mostly rostral to the zy-
mosan injection site. Thus, any changes in DRG axon growth
between the zymosan or control injection sites could be attrib-
uted to activated macrophages. When we reversed the zymosan
andDRG injection sites, we found a similar enhancement of axon
growth from the DRG transplant site toward the foci of activated
macrophages (supplemental Fig. 2, available at www.jneurosci.
org as supplemental material).
Figure 7. Macrophage activation close to neuron cell bodies impairs axon growth. A, B, Representative images of average axon growth after injecting zymosan 4mm (A) or 2 mm (B) caudal to
the DRG transplant (green, EGFP DRGs; red, OX42). In the 2 mm group, axon growth is impaired (B, D), and inflammation is enhanced in and around the graft compared with the 4 mm group (A.)
C, In29% (5 of 17) of cases, DRG grafts were not viable at 8 d if macrophages were activated within 2mm of the graft. In contrast, whenmacrophages were activated 4mm from transplants, all
transplants were viable at 8 d and extended processes over several millimeters.D, When DRGs survived in the 2mmgroup, the overall density of axonal outgrowthwas significantly reduced (*p
0.05, comparedwith the4mmgroup) aswas theaverage lengthof the longest axon (2mmzymosan, 2.9	0.4mmvs4mmzymosan, 4.8	0.4mm;p0.05).Note thatA is alsopictured in Figure
2, but without OX42 labeling. Scale bar: A, B, 146m; C, 100m.
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Macrophages activated closer to DRGs fail to promote
axon regeneration
It has been shown thatmacrophages promote robust axon regen-
eration when they are activated near the soma of injured neurons
(Lu and Richardson, 1991; Leon et al., 2000; Yin et al., 2003;
Steinmetz et al., 2005). Thus, we predicted that injecting zymosan
closer to theDRG transplantwould increase axon regeneration in
response to ZAMs. Contrary to our hypothesis, we found that
axon growth was markedly impaired and inflammation was en-
hanced in and around the graft (Fig. 7, A vs B). In fact,29% (5
of 17) of DRG transplants failed to extend axons into the spinal
parenchyma. Inmany cases, the grafts were not viable. For exam-
ple, Figure 7C is a representative DRG transplant that did not
extend axons and appears to be dying. In comparison, when zy-
mosan was injected distal (4 mm caudal) to the transplant, grafts
were always viable, and DRG neurons extended axons a mini-
mum of 4 mm into the spinal parenchyma.
ZAMs simultaneously promote axon growth and cell death
The apparent killing of transplanted DRG neurons when macro-
phages were activated closer to the transplant site made us ques-
tion the net effect of activated macrophages. That is, although
macrophages can enhance axon regeneration, does the regenera-
tive response compensate for or overshadow the ability of acti-
vated macrophages to kill neurons and glia? Also, do all macro-
phages promote regeneration and toxicity regardless of how they
are activated?
ZAMs kill neurons in the DRG
Steinmetz et al. (2005) showed that intraganglionic injection of
zymosan activates macrophages and promotes functionally sig-
nificant regeneration of injured DRG axons; however, ZAM tox-
icity was never evaluated in their preparation. In that model,
ZAMs colocalizewith the somaofDRGneurons. Based ondata in
Figure 7, we predicted that intraganglionic ZAMs would kill at
least a portion of DRG neurons. Using a modification of the
Steinmetz model, we injected into intact L4/L5 DRGs 10% of the
volume and concentration of zymosan (1.25 g in 100 nl) that
was shown by Steinmetz et al. (2005) to promote axon regenera-
tion. This dose/volume approximated what was injected into the
spinal cord in Figures 2–7.Despite themarkedly reduced concen-
tration of zymosan in our preparation, robust inflammation and
neurotoxicity were evident in the DRGwithin 72 h. For example,
when we cut and quantified neurons throughout the depth of an
injection site, we found that33% of DRG neurons were killed
(Fig. 8). PBS injections into the contralateral ganglia failed to
elicit inflammation or promote neuronal killing (Fig. 8).
ZAMs are neurotoxic in the spinal cord
We have previously shown that clodronate liposomes selectively
kill circulating monocytes and reduce the accumulation of in-
traspinalmacrophages after traumatic SCI (Popovich et al., 1999;
Popovich et al., 2003). This technique removes most circulating
monocytes and is a proven way to minimize the recruitment of
bloodmonocytes to sites of inflammation (van Rooijen andVan-
nieuwmegen, 1984). To determinewhether the neurotoxic effects
of intraspinal zymosan are caused by monocyte-derived macro-
4
Figure8. ZAMsareneurotoxic inDRGs. Serial sections cut through cresyl violet-stainedDRGs
injectedwith PBS (control) or zymosan (3 d after injection) revealmarked cell loss and gliosis in
zymosan-injected ganglia. In this specimen, DRG neurons were decreased33% by zymosan
versus neurons in PBS-injected DRGs. Scale bar, 200m.
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phages (as opposed to resident microglia), clodronate liposomes
or PBS (control) were injected intravenously on days 1, 3, and 6
after intraspinal zymosan injection. Clodronate liposomes signif-
icantly reduced macrophage-mediated damage at the site of in-
jection. Specifically, the area of activated macrophages was re-
duced by50% and was accompanied by a significant reduction
in lesion area (Fig. 9). These data suggest that monocyte-derived
macrophages cause a substantial portion of zymosan-induced
pathology.
Macrophage-mediated axon regeneration and neurotoxicity
in vitro
As shown above, intraspinal macrophage activation has dramatic
effects on glia and axons in the milieu immediately surrounding
the site of macrophage activation. Depending on where macro-
phages are activated relative to the soma of the regenerating ax-
ons, growth or toxicity was observed. To refine these analyses
further, we tested the direct effects of ZAMs on neurons by stim-
ulating adult DRG neurons in vitrowith medium conditioned by
unstimulated or zymosan-stimulated macrophages. Macro-
phages were derived from primary bone-marrow cells as de-
scribed previously (Longbrake et al., 2007). Importantly, these
cells mimic the functional potential of macrophages that infil-
trate the injured spinal cord (Longbrake et al., 2007).
When DRG neurons were exposed for 24 h to ZAM-
conditioned medium (zymosan MCM), the overall complexity
and length of DRG axons was increased compared with medium
or unstimulatedMCM, verifying the growth-promoting effect of
ZAMs (Fig. 10). These dramatic effects (as illustrated in Fig. 10A)
were easily quantified using a modified Sholl analysis (Fig. 10B)
(Sholl, 1953). However, in these same cultures, the total neuron
number was decreased relative to control wells (Fig. 10C). When
plotted as function of axon branching and overall axon length
(i.e., regenerative index), the number of surviving DRG neurons
decreased as indices of regeneration increased. These data suggest
that macrophages simultaneously release a mixture of pro-
regenerative and neurotoxic factors and that a subset of neurons
is resistant to the neurotoxic effects of in-
flammation, at least after 24 h of
incubation.
Because the net effect of these toxins
and growth factors should be revealedwith
longer exposure times, we extended the
length of time that neurons were exposed
to MCM. Prolonged exposure is relevant
to in vivo pathology since macrophages
persist at sites of CNS inflammation for
many weeks. After 48 h in vitro, the
growth-promoting effects of zymosan
MCMwere lost. Instead of seeing neurons
with long and elaborate axons like those
found at 24 h, a large proportion of DRG
neurons were degenerating or had already
died (Fig. 11A,B). The amount of cell
death exceeded that observed after 24 h of
stimulation with zymosan MCM (Fig.
11B). Of those neurons that appeared
healthy, the overall length and complexity
of their axons was decreased relative to
controls (Fig. 11C).
Yin et al. (2003) showed that reducing
the concentration of zymosan injected
into the eye increased the survival of RGCs
while maintaining improved axon regen-
eration through the injured optic nerve (Yin et al., 2003). In an
attempt to uncouple the neurotoxic and pro-regenerative effects
of ZAMs, we applied serial dilutions of zymosan MCM to DRGs
as above. We found that the regenerative and toxic effects could
be partially titrated but never uncoupled (supplemental Fig. 3,
available at www.jneurosci.org as supplemental material). For
example, a 1:2 dilution of zymosan MCM promoted slightly
more DRG axon growth than “neat” zymosan MCM at 24 h
(supplemental Fig. 4A, available at www.jneurosci.org as supple-
mental material); however, by 48 h the diluted media samples
were equally neurotoxic and were unable to enhance DRG axon
growth (supplemental Fig. 3A,B, available at www.jneurosci.org
as supplemental material).
To test whether neuronal killing by ZAMs was specific for
sensory neurons, the above assays were repeated using cultures of
cortical neurons.Mouse cortical neuronsweremostly resistant to
killing by unstimulated MCM (Fig. 12); however, toxicity was
markedly enhanced by zymosan MCM.
The growth-promoting and neurotoxic potential of
macrophages is ligand dependent
Zymosan activates spinal cord microglia and blood monocytes
predominantly by Toll-like receptor-2 (TLR2) (Carlo and Fiore,
1958; Gantner et al., 2003; Underhill, 2003). Via this receptor,
intracellular signaling cascades could trigger pro-regenerative
and neurotoxic functions in CNS macrophages. To determine
whether other modes of macrophage activation can simulta-
neously elicit axon growth and cell killing, we repeated the in vivo
and in vitro assays described above after stimulatingmacrophages
with the classical pro-inflammatory stimulus and TLR4 agonist,
LPS.
Using our in vitro assay of neuron death, LPSMCMwas found
to be only mildly neurotoxic (not significantly different from
control MCM or medium) to DRG neurons after 24 or 48 h of
exposure (Fig. 11B). Furthermore, LPS MCM had no effect on
DRG axon length [254 	 27 (unstimulated) vs 337 	 34 m
Figure 9. Intraspinal zymosan causes pathology in part via recruitment of blood monocytes. A, Zymosan microinjection
potently activates CNS macrophages (OX42 cells) at the site of injection within 7 d. B, The zymosan-mediated macrophage
response is significantly reduced in macrophage-depleted subjects. C, D, Adjacent sections stained with neurofilament (NF)
antibody show that ZAMs cause axonal pathology (C), which is significantly reduced after macrophage depletion (D). Images are
from subjects representing the statistical mean for the control (A, C) and macrophage-depleted (B, D) groups. E, Quantitative
analysis of images inA—D confirm thatmacrophage depletion reduces intraspinal accumulation ofmacrophages50%with a
concomitant decrease in axon pathology (*p 0.05, vs controls). Scale bar: A–D, 100m.
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(LPS); p 0.059] or branching complexity [28.4	 3.5 (unstimu-
lated) vs 32.5 	 3.4 (LPS); p  0.409] after 24 h, but the com-
plexity of axonal branching was reduced in DRG neurons after
48 h (Fig. 11C). In contrast to DRGs, LPS MCM (24 h) was toxic
to cortical neurons (Fig. 12C).
As we have reported previously, intraspinal injections of LPS
activates macrophages but does not cause marked pathology to
neurons or myelin (Fig. 13A,B) (Schonberg et al., 2007). Despite
the absence of overt pathology at/near the LPS injection site (Fig.
13A,B), TLR4-mediatedmacrophage activation did not enhance
growth of transplanted DRG axons. This was true whether LPS
was injected distal (4 mm) or proximal (2 mm) to the transplant
(Fig. 13C). Thus, LPS-activated macrophages are less neurotoxic
than ZAMs but they also lacked the ability to stimulate axon
growth, suggesting again that the pro-regenerative and neuro-
toxic effects of activated macrophages are coupled.
Discussion
CNS trauma elicits a macrophage response composed of resident
microglia and blood monocytes. Collectively, these cells are be-
lieved to be essential for promoting CNS remyelination and re-
generation of injured CNS axons (Rapalino et al., 1998; Kotter et
al., 2001; Benowitz and Yin, 2007). Attempts to augment this
repair capacity in humans culminated in a phase I autologous
macrophage transplantation (ProCord) trial for treating acute
SCI (Knoller et al., 2005). It was predicted that injecting activated
macrophages into the caudal pole of SCI lesions would improve
removal of inhibitorymolecules and create a gradient of tropic or
trophic factors leading to enhanced axon growth across/around
sites of injury (Schwartz et al., 1999). Although phase II trials
were suspended for unspecified reasons, the advent of this trial
underscores the hope for manipulatingmacrophages to promote
CNS repair. Unfortunately, macrophages also kill neurons and
glia as a normal part of their conserved response to tissue damage
(for review see, Popovich and Longbrake, 2008).
In the CNS, the idea that macrophages can exert divergent
functions is appreciated but rarely documented, especially in
vivo. Indeed, the range of ligand/receptor interactions involved in
shapingCNSmacrophage function in a given context is primarily
unknown. Also, it is difficult to separate the injury/repair effects
of activated macrophages from those initiated by other cells di-
rectly affected by trauma. Here, we used controlled in vivo and in
vitro models to unequivocally show that activated macrophages
simultaneously promote axon regeneration and neurotoxicity.
Regenerating DRG axons course through a permissive glial sub-
strate induced by activated macrophages. These axons then
abruptly turn or “die back” as they encounter macrophage foci
composed of mostly recruited blood monocytes, the latter of
which cause pathology and were associated with a growth inhib-
itory CSPG “cloud.” This mimics what happens when axons en-
counter macrophage-enriched lesions created by acute trauma
(Davies et al., 1999; Horn et al., 2008) and may have caused us to
underestimate the magnitude of axon growth stimulated by
ZAMs in our model. An examination of axon growth at earlier
times after DRG/zymosan injection would be needed to test this
hypothesis.
When macrophages were activated close to DRG soma,
macrophage-mediated killing predominated. The toxic effects of
intraganglionic zymosan injection were intriguing (Fig. 8) since
coupling zymosan injections with CSPG degradation has been
shown to promote regeneration of injured DRG axons in vivo
(Steinmetz et al., 2005). Furthermore, using zymosan and LPS as
prototypical stimuli that elicit a range of macrophage functions
relevant toCNS injury/repair, we show that not all activatedmac-
rophages are equally adept at causing tissue repair or cell killing.
Given that traumatic CNS injuries elicit a similarly heteroge-
neous macrophage response, these data illustrate the complexi-
ties and challenges of controlling andmanipulatingmacrophages
with the goal of repairing the CNS.
Macrophage-mediated regeneration is coupled
with neuropathology
Clearly, simply removing or augmenting the effects of these cells
at sites of injury cannot easily predict macrophage-mediated ef-
Figure10. ZAMs simultaneouslypromoteaxongrowthandkillingofDRGneurons in vitro.A,
-Tubulin III-stained cellular profiles representative of the average branching complexity and
axon length of neurons from cultures treated for 24 h with media, unstimulated MCM, or
zymosan-stimulated MCM. Scale bar, 40 m. B, A semiautomated quantification scheme,
based on the technique of Sholl (1953) (see also Materials and Methods), was used to quantify
the effects of differentMCMs on axonal sprouting and axon length. In each case, zymosanMCM
significantly increased these indices of growth/regeneration (***p 0.001, zymosan vs me-
dia; **p 0.01, zymosan vs unstimulatedMCM). C, An inverse relationship exists between the
overall axon regenerative index (composite of axon branching and length) and neuron survival.
Note that zymosan MCM stimulates extensive axon growth while promoting neuronal killing.
Cell killing was inferred based on fewer cells per coverslip despite plating equal numbers of
DRGs in each well.
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fects on axon growth and cell death. Systemic depletion of circu-
lating monocytes reduces pathology and improves regenerative
sprouting at sites of contusive SCI (Popovich et al., 1999) but has
no effect on the ability of intraocular inflammation to promote
regeneration of injured RGCs (Hauk et al., 2008). In the present
study, macrophage depletion reduces pathology caused by focal
intraspinal injection of zymosan, but it is difficult to predict
whether this would affect DRG axon growth since the positive
and negative aspects of the activated macrophages would be lost.
Gain-of-function studies targeting CNS macrophages may be
equally ambiguous. For example, in a SCI model, LPS-activated
macrophages enhanced phagocytic removal ofmyelin growth in-
hibitory proteins, but without causing toxicity or regeneration
(Vallieres et al., 2006). Collectively, these data underscore the
importance of understanding how the lesion microenvironment
influences epigenetic regulation of macrophage function and
how those functions influence cell survival or repair.
In vivo, we found that ZAMs promote axon growth when they
are activated distal to axon growth cones.Macrophages have been
shown to modify the astrogliotic scar and enhance the growth-
permissiveness of injured CNS tissue, in part through increased
astrocyte production of brain-derived neurotrophic factor
(BDNF) andCNTF (David et al., 1990; Savli et al., 2004;Muller et
al., 2007;Wu et al., 2007). In ourmodel, astrocytes create a CNTF
gradient emanating from the edge of zymosan injection (Fig. 4).
Notably, CNTF was not increased in the ZAM foci, which may
explain why DRG axons grew toward but not through ZAMs.
However, other cells and trophic factors undoubtedly synergize
to promote axon growth. As proteins of different molecular
weight diffuse from the ZAM foci, they could create microenvi-
ronments with distinct effects on axon growth/neuron survival.
Indeed, Yin et al. (2003) showed that ZAM-derived neurotoxins
and neurotrophic factors can be separated based on molecular
weight with neurotoxins being larger than macrophage-derived
neurotrophic factors. If we consider the spinal cord as an in vivo
filtration “gel,” we would expect neurotoxic factors to migrate
slowly and remain nearby ZAM foci while neurotrophic factors
would diffuse more freely. This may explain why ZAMs activated
close to the DRG transplant site caused neuron atrophy and axon
collapse. It also suggests that the effectswe observed in vitro, using
MCM, reflect an initial growth-promoting effect of neurotro-
phins that are subsequently overridden by neurotoxic molecules.
Future studies are needed to establish how different stimuli in the
lesionmicroenvironment controlmacrophage function and then
relate these changes to neuron survival and axon growth.
Modeling the consequences of macrophage activation in CNS
The opposing functions of CNS macrophages on neurons and
glia in vivo are undoubtedly triggered by an array of receptor/
ligand interactions. Of these, TLRs play a fundamental role in
regulating the balance between macrophage-mediated injury/re-
pair (Nguyen et al., 2002; Kigerl et al., 2007). In the CNS, TLRs
are found mostly on microglia and macrophages (Laflamme and
Rivest, 2001; Zekki et al., 2002), although astrocytes, oligoden-
drocytes, stem cells, and neurons also express TLRs (Bsibsi et al.,
2002; Ma et al., 2006; Cameron et al., 2007; Rolls et al., 2007). At
sites of injury, TLRs bind endogenous non-pathogenicmolecules
known as danger-associatedmolecular patterns (DAMPs). These
naturally occurring TLR ligands may serve a physiological role in
alerting macrophages to changes in tissue homeostasis (Zhang
and Schluesener, 2006; Bianchi, 2007). Many DAMPs, including
heat shock proteins, necrotic cell debris, degradation products of
the extracellular matrix (e.g., fibronectin, hyaluronic acid), high-
Figure 11. Prolonged exposure of neurons to zymosan MCM results in toxicity and axonal
degeneration. A, Examples of-tubulin III DRG neurons exposed for 48 h to unstimulated or
zymosan MCM. After 48 h, neurons exposed to zymosan MCM become dystrophic and begin to
degenerate. Scale bar, 180m. B, A comparison of DRG neuron survival at 24 and 48 h after
stimulationwith controlmediaor different typesofMCM.Only zymosanMCMkills neurons after
48 h of stimulation (*p 0.05, vs 24 h zymosanMCM). C, Quantification of neuronswith intact
axons in each group show that prolonged stimulation with zymosan MCM reduces the overall
complexity and length of DRG axons (**p 0.01, compared with control media; *p 0.05,
compared with unstimulated MCM). Interestingly, 48 h MCM from LPS-stimulated macro-
phages also reduces axonal branching ( p 0.05, vs unstimulated MCM) but not length.
Gensel et al. •Macrophages Promote Regeneration and Neurotoxicity J. Neurosci., March 25, 2009 • 29(12):3956–3968 • 3965
mobility group box 1, and mRNA exist at
sites of CNS injury and could help shape
the divergent functions of CNS macro-
phages (Basu et al., 2000; Li et al., 2001;
Okamura et al., 2001; Termeer et al., 2002;
Yu et al., 2006). However, it is not yet
known which DAMPs predominate in a
given pathological condition or whether
these molecules can be used as reliable
model stimuli for triggering macrophage
responses of relevance to CNS injury. For
example, it is known that degenerating
DRG neurons release nonproteinaceous
byproducts that induce a TLR2 and possi-
bly TLR4-dependent pro-inflammatory
phenotype inmicroglia (Tanga et al., 2005;
Kim et al., 2007). Activated in this way,
microglia can be toxic to neurons and
glia (Lehnardt et al., 2006). In contrast, a
variety of DAMPs trigger macrophages to
release growth factors. For example, onco-
modulin, glial cell line-derived neurotro-
phic factor (GDNF), BDNF, and NGF are
released from activated macrophages and
increase axonal outgrowth from different
types of neurons (Lentz et al., 1999; Batch-
elor et al., 2002; Yin et al., 2006; Nakajima
et al., 2007).
Zymosan and LPS, pathogenic TLR2, and TLR4 ligands, re-
spectively, activate microglia/macrophages in vivo and produce a
spectrum of the injurious and reparative responses found in
models of traumatic CNS injury (Fitch et al., 1999; Popovich et
al., 2002; McPhail et al., 2004; Hossain-Ibrahim et al., 2006; Val-
lieres et al., 2006; Schonberg et al., 2007). Here, we used these
ligands to induce a robust and predictable inflammatory re-
sponse at the leading edge of growing axons and noted both
positive and negative effects. Although these stimuli may repre-
sent extremes in the activation sequence triggered by CNS injury,
they cannot be dismissed as irrelevant since they trigger highly
conserved intracellular signaling pathways that elicitmacrophage
functions relevant in CNS injury. Intraspinal injection of zymo-
san elicits monocyte recruitment and creates a gradient of acti-
vatedmicroglia and astrocytes that radiate from the injection site
(Fig. 3). This resembles the cellular response elicited by contusive
SCI or axonal transection in the brain (Popovich et al., 1997;
Batchelor et al., 1999). Just like zymosan, axon transection in
brain activates microglia in a TLR2-dependentmanner (Babcock
et al., 2006) creating a gradient ofGDNF andBDNF that supports
regenerative sprouting (Batchelor et al., 1999), reminiscent of
data shown in Figure 4. Axons grow through these gradients but
not into or through inflammatory foci enriched with monocyte-
derived macrophages. Again, this mimics how axons respond as
they negotiate macrophage-enriched necrotic foci in hemor-
rhagic lesions caused by brain trauma or SCI. A remaining chal-
lenge is to define the endogenous factors that trigger pro-
regenerative and neurotoxic functions in macrophages and learn
how to manipulate the resultant signaling pathways to maximize
CNS repair.
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